Skip to content

The study on the Glycemic Index of white bread with food grade Mulberry leaf extract (Reducose) at 3 dose levels

The Impact of Mulberry Leaf Extract at Three Different Levels on Reducing the Glycemic Index of White Bread

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100044474
Enrollment
Unknown
Registered
2021-03-18
Start date
2019-11-08
Completion date
Unknown
Last updated
2022-02-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prediabetes and diabetes

Interventions

experimental group 1:White Bread with Mulberry Leaf Extract at grade I (0.75%)
Experimental 2:White Bread with Mulberry Leaf Extract at grade II (1.25%)
Experimental 3:White Bread with Mulberry Leaf Extract at grade III (1.5%)

Sponsors

China National Research Institute of Food & Fermentation Industries Co.,Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 37 Years

Inclusion criteria

Inclusion criteria: 1.Healthy adults between the ages of 18 and 40 years; 2.With normal body weight, BMI between 18.5-24.0 kg/m2, without metabolic disease, digestive disease, or endocrine disease; 3.Without history of diabetes, or use of hypoglycemic drugs; 4.Without history of food allergy or intolerance, or history of blood phobia; 5.Without use of drugs that affect glucose tolerance in the past 3 months. Oral stable dose of contraceptives, acetylsalicylic acid, thyroxine, vitamins and mineral supplements, or drugs to treat hypertension or osteoporosis are acceptable; 6.Able to tolerate fasting for at least 10 hours.

Exclusion criteria

Exclusion criteria: 1. Known history of diabetes or the use of anti-hyperglycemic drugs or insulin to treat diabetes and related diseases; 2. Major medical or surgical events in the past 3 months that require hospitalization; 3. The presence of diseases or drugs that affect the digestion and absorption of nutrients; 4. Use of steroids, protease inhibitors, or antipsychotics (all of which have significant effects on glucose metabolism and body fat distribution).

Design outcomes

Primary

MeasureTime frame
Blood glucose;Glycemic Index;

Countries

China

Contacts

Public ContactLiu Jia

China National Research Institute of Food & Fermentation Industries Co., Ltd.

liujiajessica@163.com+86 10 5321 8288

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026